-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMACEUTICAL SHARES UP 8.6% PREMARKET AFTER SECURING FDA NOD FOR RARE METABOLIC DISORDER GENE THERAPY

Reuters·08/20/2026 11:02:51

Please log in to view news